CEDAR KNOLLS, N.J., April 13, 2009 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its Eligen(r) Technology, today announced that President and Chief Executive Officer, Michael V. Novinski, will present at the New York Biotechnology Association's ("NYBA") 18th Annual Meeting at 2:10 PM EDT on Monday, April 20, 2009 in the Belasco Room of the Marriot Marquis Hotel in New York City.
